SCHEMBL22766344

SCHEMBL22766344

CSc1c[nH]c2cccnc12

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PSMD14 O00487 1/20 0.44
▸ GRM4 Q14833 2/20 0.40
▸ L3MBTL1 Q9Y468 2/20 0.37
▸ KDR P35968 1/20 0.36
▸ FLT3 P36888 1/20 0.36
▸ GSK3B P49841 1/20 0.36
▸ KDM4E B2RXH2 3/20 0.36
▸ NPSR1 Q6W5P4 1/20 0.36
▸ HSP90AA1 P07900 2/20 0.35
▸ NPC1 O15118 1/20 0.35
▸ PRKD3 O94806 1/20 0.35
▸ PRKD1 Q15139 1/20 0.35
▸ PRKD2 Q9BZL6 1/20 0.35
▸ PARP1 P09874 3/20 0.35
▸ KCNMA1 Q12791 2/20 0.35
▸ MAPT P10636 2/20 0.34
▸ GMNN O75496 1/20 0.34
▸ LMNA P02545 1/20 0.34
▸ TP53 P04637 1/20 0.34
▸ MMP2 P08253 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13978040 0.80 PSMD14 (0.43) PSMD14GRM4KDRFLT3GSK3B
SCHEMBL369216 0.75 PSMD14 (0.48) PSMD14GRM4L3MBTL1KDRFLT3
Potassium SCHEMBL3219697 0.73 PSMD14 (0.47) PSMD14GRM4L3MBTL1KDRFLT3
SCHEMBL3219684 0.73 PSMD14 (0.47) PSMD14GRM4L3MBTL1KDRFLT3
SCHEMBL7743849 0.71 MAPK1 (0.50) KDRFLT3GSK3BPRKD3PRKD2
SCHEMBL13978041 0.71 PSMD14 (0.48) PSMD14GRM4L3MBTL1KDRFLT3
SCHEMBL569155 0.71 AXL (0.50) PSMD14GRM4KDRFLT3GSK3B
SCHEMBL22510135 0.71 PSMD14 (0.48) PSMD14GRM4L3MBTL1KDM4EHSP90AA1
SCHEMBL3175822 0.71 PSMD14 (0.48) PSMD14GRM4KDRFLT3GSK3B
SCHEMBL19100792 0.71 GRM4 (0.54) PSMD14GRM4L3MBTL1KDM4EHSP90AA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200385382-A1 6-AZAINDOLE COMPOUNDS BRISTOL MYERS SQUIBB CO (US) 2020-12-10 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200385382-A1 6-AZAINDOLE COMPOUNDS TLR7, TLR9, TLR5 PSMD14 4789/4885GRM4 414/4885L3MBTL1 4223/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback